+ND Capital

3B Future Health Ventures

3Brain AG

AAA Family Office

AC Immune

Aerska

AL-S Pharma AG

Alzheimer's Research UK Oxford Drug Discovery Institute, University of Oxford

Ampleia

Amporin Pharmaceuticals AG

Amyl Therapeutics SRL

AndzonBio2

Angelini Pharma S.p.A.

Angelini Ventures S.p.A.

Apollo Health Ventures

Aprecia Pharmaceuticals

ARTCLINE GmbH

Asklepios Advisors

Astr Partners

Aukera Therapeutics GmbH

Awen GmbH

BERNINA BioInvest Ltd.

BioArctic AB

Biocytogen

BioGeneration Ventures (BGV)

BioMedPartners AG

BioPharma Drug Licensing Group SL

BIOSTART Consulting GmbH

Biovision Ventures

Bioxodes SA

Boehringer Ingelheim International GmbH

Bootstrap Europe

Brenig Therapeutics

Breslin AG

Brutkasten GmbH / VentureCapital Magazin

Business Angels Switzerland

Caladrix Pty Ltd.

Cancer Research Horizons

CaSRevolution S.r.l.

Claris Ventures SGR SpA

Clinilabs, LLC

CMS Medical Venture Investment Ltd.

Cohesion Bureau

Coho VC

Compass Pathways

CONNECTA Therapeutics, S.L.

Convergence Partners

Corinthian financial management Ltd

Cukierman & Co. Life Sciences

Curie.Bio

Curlim

DeBere Capital Partners

Dementia Discovery Fund, an SV Health Investors, LLC Fund

Digital Networks PLC

DOLINNOV

Eli Lilly and Company

Elkedonia SAS

European BrainTech Fund

Evernow Publishing Ltd, publisher of MedNous

Evox Therapeutics Ltd.

F. Hoffmann-La Roche

FluoSphera SA

Fortlane Partners GmbH

Forty51 Ventures AG

FreeMind Group

Galimedix Therapeutics, Inc.

Genius Search GmbH & Co. KG

GHF - Golden Heart Flower Ltd.

GIBF

Gilde Healthcare Partners BV

Gimv

Gold Nest Capital

H. Lundbeck A/S

HBM Partners AG

Hevolution

IAMA Therapeutics S.r.l.

InnoMedica Schweiz AG

Innovestor Life Science Ltd.

Innunity Therapeutics

Inveready Asset Management

IPF Partners

IQ Capital

J.P. Morgan Switzerland

Kerna Ventures

Kurma Partners

Lario Therapeutics Ltd.

Limani Partners

LINK Medical

LMU Munich

Lonza AG

Lumanity

Lumina Life Sciences

M&G Advisors GmbH

M2care Venture Studio

Macomics Ltd.

Medicines Discovery Ventures

MEDiSTRAVA

Modi VC

Montis Biosciences BV

Move Venture Consulting

Naissance Capital

NatIgGs GmbH

New Harbor Venture Partners, LLC

New Science Fund

NodThera, Inc.

Novo Holdings A/S

NRx Pharmaceuticals, Inc.

OncoNex-Remunity Therapeutics SAS

Ontario Brain Institute

OPIS s.r.l.

OrbiMed

Otsuka Pharmaceutical Co., Ltd.

Oxford Science Enterprises

Panakès Partners SGR SpA

Pangea Bio Ltd.

Panntherapi SAS

Parkinson's Research Ventures Ltd

Point6 Bio

Pureos Bioventures

Qynapse

Reconnect Labs AG

Remynd NV

Roy Consulting

RV Invest GmbH

Sappiens SAS

Scenic Biotech B.V.

SCI Ventures LLC

Scienion GmbH

SEQENS

Serenatis Bio

Serpentine Ventures

Servier

Seventure Partners

Shanda Grab Ventures Limited

Shionogi B.V.

SpliceBio, S.L

Super Capital

Sygnature Discovery Limited

Synendos Therapeutics AG

The Fulford Group Ltd.

The Michael J. Fox Foundation for Parkinson's Research

Torrey Pines Investment

TRIMTECH Therapeutics

UCEA Family Office

Ultimate Medicine AG

UNEEG Medical A/S

uniQure

University of Zurich

V-Bio Ventures BV

Valor Management

Vandria SA

Vectrix Health

Versant Ventures

Verve Ventures

VI Partners AG

VIB

Wellington Partners

Worldwide Clinical Trials

XGEN Venture SGR S.p.A.

XOventure GmbH

Y-king Biologics

YAYA Capital

Ysios Capital